Cannabis Global (CBGL) Return on Equity ROE from the third quarter 2022 to third quarter 2021 and annually, average high and low, overall ranking from May 31 2022 to May 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cannabis Global Inc.  (CBGL)

Cannabis Global's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Cannabis Global in the third quarter 2022?
Cannabis Global Inc. recorded a cumulative net loss of $-4 million during 12 months ending in the third quarter 2022, resulting in a negative return on equity (ROE) of -66.53%.

Within the Biotechnology & Pharmaceuticals industry 104 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2022 from 0 to 3855.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (May 31 2022)
III. Quarter		 (Feb 28 2022)
II. Quarter		 (Nov 30 2021)
I. Quarter		 (Aug 31 2021)
IV. Quarter		 (May 31 2021)
III. Quarter
Y / Y Equity Change 113.13 % 86.21 % - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -4 -6 -7 -8 -6
Return On Equity (TTM) -66.53 % -135.07 % -220.48 % -391.2 % -453.99 %
CBGL's Total Ranking # 3855 # 0 # 0 # 0 #
Equity (TTM) in Millions 8 8 4 1 4
Seq. Equity Change -3.91 % 91.35 % 205.71 % -62.08 % -16.05 %
Seq. Net Income Change - - - - -

Back to CBGL Management Effectiveness >> CBGL's 5 Years Annual ROE >> Compare CBGL ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 105
Sector # 667
Overall # 3855

Return On Equity Statistics
High Average Low
-66.53 %
-298.82 %
-786.74 %
(May 31 2022)   (Aug 31 2021)





CBGL Annual Return On Equity (Aug 31 2021)
2021		 (Aug 31 2020)
2020		 (Aug 31 2019)
2019		 (Aug 31 2018)
2018		 (Aug 31 2017)
2017
Total Equity in Millions 1 -1 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -8 -5 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -598.61 % - -634.37 % - -

Back to CBGL Management Effectiveness >> CBGL's 5 Years Annual ROE >> Compare CBGL ROE to its Competitors




More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CBGL's' Return on Equity at Yahoo Finance
CBGL's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CBGL's Competitors
Subscribers only: Roe for Cannabis Global's Suppliers
Subscribers only: Return On Equity for CBGL's Customers




Companies with similar Return On Equity at May 31 2022, within Healthcare Sector ROE

Date modified: 2026-09-08T15:10:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.